Eli Lilly and Company
PulseAugur coverage of Eli Lilly and Company — every cluster mentioning Eli Lilly and Company across labs, papers, and developer communities, ranked by signal.
1 day(s) with sentiment data
-
Pharma giants Eli Lilly and Nvidia partner to accelerate AI drug discovery
Eli Lilly and Company has partnered with Nvidia to develop a powerful supercomputer aimed at accelerating drug discovery using artificial intelligence. This collaboration, announced in October and expanded in January wi…
-
Eli Lilly raises full-year revenue forecast after Q1 sales jump 56%
DeepSeek has released a significant update to its AI models, marking a notable advancement for the company. This update comes as Eli Lilly reported a 56% year-over-year revenue increase for its first quarter, leading th…
-
DeepSeek announces major update, Eli Lilly raises full-year guidance
DeepSeek has announced a significant update, marking a new phase for the company. The update is accompanied by news that Elon Musk stated he co-founded OpenAI with the intention of saving humanity. Additionally, Samsung…
-
Eli Lilly bets $2.75B on AI-designed drugs, signaling pharma's AI shift
Eli Lilly has invested $2.75 billion in Insilico Medicine, a Hong Kong-based company that uses AI for drug discovery. This significant deal highlights the growing trend of major pharmaceutical companies committing subst…
-
Google DeepMind spinoff Isomorphic Labs raises $2.1B for AI drug trials
Isomorphic Labs, an AI-driven drug discovery company spun out of Google DeepMind, has secured over $2 billion in a Series B funding round. The substantial investment, led by Thrive Capital, will be used to expand its pr…
-
AI falls short in cancer fight, experts say; deeper AI needed
AI has not yet delivered on its promise to significantly impact cancer treatment, despite hopes that advanced algorithms could revolutionize drug discovery and development. Critics argue that the challenges in medicine …